HIGHLIGHTS
- who: Alessia Filippone and collaborators from the Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D`Alcontres, , Messina, Italy have published the research work: Protein Kinase Inhibitors as a New Target for Immune System Modulation and Brain Cancer Management, in the Journal: (JOURNAL)
- what: The study showed that inhibition of CSF-1R signaling using PLX3397 reduced the number of microglia/macrophages and significantly inhibited invasiveness. This study showed that in the mouse model of GBM, treatment with Sunitinib reduced the number of MDSCs which coincided with an increase in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.